An Interview With Nima Kokabi, MD, FRCPC
Dr. Kokabi explains his collaborative, personalized medicine approach to interventional oncology, knowledge gaps for Y90 dosimetry for hepatocellular carcinoma, updates on the Road2IR training program in East Africa, and more.